Message from the Managing Director’s Desk

At Novum Pharmaceutical Research Services, our dedicated focus revolves around providing comprehensive end-to-end clinical research services to the global innovator, biotech, and generic pharmaceutical industries. We consistently set new standards in the clinical research sector, achieving milestones through both organic growth and strategic acquisitions.

In 2019, Lambda Therapeutic Research strategically expanded its North American presence by acquiring Novum Pharmaceutical Research Services, a distinguished 50-year-old CRO. This strategic move, following the integration of Biovail’s R&D facilities in Canada in 2010, marked Lambda’s second significant acquisition in North America. Operating under the unified brand of Novum Pharmaceutical Research Services in North America, Lambda reinforces its position as a key player in the global CRO market.

Read More
Services

​Turnkey Clinical Trial Management solution for YOUR drug development programs

Guided by a senior management team with expertise in science, operations, quality assurance, medical affairs and project management, Novum offers the highest levels of integrity and reliability.

Early Phase CRO
Company

Nearly fifty years of high-quality research outcomes.

Novum is a full-service CRO with an impeccable performance record and numerous FDA approvals in new drug, 505(b)(2) and ANDA submissions. We manage complex studies across numerous therapeutic areas and dosage forms, spanning early phase to late phase trials. With the full integration of our bioanalytical unit in Toronto, Canada in 2020, Novum is poised to continue its longstanding tradition of serving clients with safety, quality, and scientific leadership.

Contact Us

Let’s Talk

There are plenty of ways to get in touch. Just select the one that is best for you.

Careers

Novum prides itself on its talented and dedicated team of employees. The Novum team is passionate about customer satisfaction, safety and study integrity. All Novum clinical staff members receive extensive training designed to continually hone and increase the skills of each employee.

clinical data management company

Want to participate in a study?

Last year we paid over $6.6 million to participants of our research studies.